United States · Bill · S
S. 3129 (116th)
Lower Costs, More Cures Act of 2019
Introduced
19 December 2019
Last action
19 December 2019 · Introduced
Status
Read twice and referred to the Committee on Finance.
Sponsors
Sen. Crapo, Mike [R-ID], Sen. Enzi, Michael B. [R-WY], Sen. Burr, Richard [R-NC], Sen. Barrasso, John [R-WY], Sen. Tillis, Thomas [R-NC], Sen. Risch, James E. [R-ID], Sen. Ernst, Joni [R-IA], Sen. Perdue, David [R-GA], Sen. Scott, Tim [R-SC], Sen. Daines, Steve [R-MT]
Subjects
Healthcare
Source updated
3 January 2025
Summary
Lower Costs, More Cures Act of 2019 This bill establishes and modifies several requirements to address prescription drug prices under Medicare. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing under the Medicare prescription drug benefit, and establishes several reporting requirements for drug manufacturers with respect to drug prices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 December 2019
Introduced
Read twice and referred to the Committee on Finance.
Source: IntroReferral
19 December 2019
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 19 December 2019 · Download file
Documents
3 official files
Introduced in Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (text)
Introduced in Senate · EN · 19 December 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 19 December 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 19 December 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Crapo, Mike [R-ID] · R · Sponsor
- Sen. Enzi, Michael B. [R-WY] · R · Sponsor
- Sen. Burr, Richard [R-NC] · R · Sponsor
- Sen. Barrasso, John [R-WY] · R · Sponsor
- Sen. Tillis, Thomas [R-NC] · R · Sponsor
- Sen. Risch, James E. [R-ID] · R · Sponsor
- Sen. Ernst, Joni [R-IA] · R · Cosponsor
- Sen. Perdue, David [R-GA] · R · Cosponsor
- Sen. Scott, Tim [R-SC] · R · Cosponsor
- Sen. Daines, Steve [R-MT] · R · Cosponsor
- · ssfi00 · Standing
Related records
- related to → Payment Commission Data Act of 2019
- related to → Payment Commission Data Act of 2019
- related to → Restoring Access to Medication Act of 2019
- related to → To amend the Internal Revenue Code of 1986 to permanently extend the 7.5 percent adjusted gross income floor for the medical expense deduction.
- related to → Drug Price Transparency Act
- related to → Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
- related to → Fixing Global Freeloading Act
- related to → Improving Low-Income Access to Prescription Drugs Act of 2019
- related to ← Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act
- related to ← Lowering Drug Costs for Seniors Act of 2020
Showing 10 of 20 related records.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/3129
- Open data entity: https://api.congress.gov/v3/bill/116/s/3129
- us · 116-s-3129 · source updated 3 January 2025